Filtered By:
Procedure: CT Scan
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 1324 results found since Jan 2013.
Relationships Between High-Resolution Computed Tomographic Features and Lung Function Trajectory in Patients With Asthma
CONCLUSIONS: Emphysema and BWT are associated with airway remodeling in asthmatics. Our simple, semi-quantitative scoring system based on HRCT may be an easy-to-use method for estimating airflow limitation.PMID:37021504 | DOI:10.4168/aair.2023.15.2.174
Source: Allergy, Asthma and Immunology Research - April 6, 2023 Category: Allergy & Immunology Authors: Joo-Hee Kim Kyung Eun Shin Hun Soo Chang Jong-Uk Lee Seung-Lee Park Jai Soung Park Jong Sook Park Choon-Sik Park Source Type: research
Management of giant-cell arteritis in Switzerland: an online national survey
CONCLUSIONS: This survey indicates that imaging and temporal biopsy are rapidly accessible for diagnosing giant-cell arteritis in Switzerland but highlights heterogeneous practice in many disease management areas.PMID:37011593 | DOI:10.57187/smw.2023.40051
Source: Swiss Medical Weekly - April 3, 2023 Category: General Medicine Authors: Michele Iudici Andrea Katharina Hemmig Mihaela Stegert Delphine Sophie Courvoisier Sabine Adler Mike Oliver Becker Christoph T Berger Diana Dan Axel Finckh Alfred Mahr Thomas Neumann Stephan Reichenbach Camillo Ribi Luca Seitz Peter Villiger Lukas Wildi T Source Type: research
Itraconazole Improved Bronchial Wall Thickness in Severe Persistent Asthma: A Double-blind Placebo-controlled Randomized Clinical Trial
Iran J Allergy Asthma Immunol. 2023 Feb 20;22(1):1-11. doi: 10.18502/ijaai.v22i1.12000.ABSTRACTThe purpose of this study was to evaluate the effect of 8 months of treatment with itraconazole on airway wall thickness in patients with severe persistent asthma. It was a double-blind, randomized, placebo-controlled clinical trial (IRCT20091111002695N9). Seventy-five subjects with severe persistent asthma received itraconazole (100 mg), prednisolone (5 mg), or placebo twice a day for eight months in three treatment groups (n=25 in each group). The primary objective was to improve the right upper lobe apical segmental bronchus (...
Source: Iranian Journal of Allergy, Asthma and Immunology - April 1, 2023 Category: Allergy & Immunology Authors: Farnaz Aligolighasemabadi Majid Mirsadraee Mohammadamin Sadeghdoust Shadi Ghaffari Mohammad Sarafraz Yazdi Saeed Naghibi Amirhossein Hashemi Attar Source Type: research
